Immunome, Inc.IMNMNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+46.7%
5Y CAGR+55.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+46.7%/yr
vs +99.2%/yr prior
5Y CAGR
+55.2%/yr
Recent deceleration
Acceleration
-52.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
9x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$42.99M+30.5%
2024$32.95M+67.7%
2023$19.66M+44.2%
2022$13.63M+22.9%
2021$11.09M+132.3%
2020$4.78M+213.1%
2019$1.52M+76.1%
2018$866000.00-